Calluna Pharma

AgomAb Therapeutics

This biopharmaceutical company develops therapies to treat fibrotic and inflammatory diseases for patients with conditions such as Crohn's disease and pulmonary fibrosis.

Granite Bio

This clinical-stage biotechnology company develops therapeutic antibodies to treat patients with inflammatory, autoimmune and fibrotic diseases.

Celea Therapeutics

The company develops deupirfenidone, an antifibrotic medicine for patients with idiopathic pulmonary fibrosis and other serious respiratory diseases.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

Endeavor BioMedicines

This clinical-stage biotechnology company develops small-molecule inhibitors and therapies for patients with oncology and fibrotic lung diseases.

Clarametyx Biosciences

This company develops immune-enabling therapies targeting bacterial biofilms for patients with chronic and progressive respiratory diseases.

Spica Therapeutics

This biotechnology firm develops monoclonal antibody therapies that target pathogenic macrophage subsets to treat patients with cancer and fibroinflammatory diseases.

Vicore Pharma

This clinical-stage biopharmaceutical company develops angiotensin II type 2 receptor agonists to treat patients with idiopathic pulmonary fibrosis and other rare lung diseases.